Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration.
about
Clopidogrel and proton pump inhibitors--where do we stand in 2012?Applications of propensity score methods in observational comparative effectiveness and safety research: where have we come and where should we go?Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendationsAre all biases missing data problems?Data for cancer comparative effectiveness research: past, present, and future potential.Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancerAdjustment for missing confounders in studies based on observational databases: 2-stage calibration combining propensity scores from primary and validation data.Misclassification in administrative claims data: quantifying the impact on treatment effect estimates."A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis".A General Framework for Considering Selection Bias in EHR-Based Studies: What Data Are Observed and Why?Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary interventionInstrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance.Developments in post-marketing comparative effectiveness researchUnderstanding secondary databases: a commentary on "Sources of bias for health state characteristics in secondary databases"Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.Who wants a free brain scan? Assessing and correcting for recruitment biases in a population-based sMRI pilot study.Medical databases in studies of drug teratogenicity: methodological issuesEffects of combination antiretroviral therapies on the risk of myocardial infarction among HIV patients.Linkage of routinely collected oncology clinical data with health insurance claims data--an example with aromatase inhibitors, tamoxifen, and all-cause mortality.Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly.Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic reviewBias formulas for sensitivity analysis of unmeasured confounding for general outcomes, treatments, and confounders.Indications for propensity scores and review of their use in pharmacoepidemiology.Incorporating linked healthcare claims to improve confounding control in a study of in-hospital medication use.Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach.Harms associated with single unit perioperative transfusion: retrospective population based analysis.Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture.Performance of propensity score calibration--a simulation study.Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision-Making.Guided Bayesian imputation to adjust for confounding when combining heterogeneous data sources in comparative effectiveness research.An imputation-based solution to using mismeasured covariates in propensity score analysisEvaluation of Healthcare Interventions and Big Data: Review of Associated Data Issues.Correcting hazard ratio estimates for outcome misclassification using multiple imputation with internal validation data.Propensity score calibration in the absence of surrogacyNeighborhood Latino ethnic density and mortality among HIV-positive Latinos by birth country/region, Florida, 2005-2008Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information.Clinical research methodology I: introduction to randomized trials.Chronic Obstructive Pulmonary Disease Increases the Risk of Hip Fracture: A Nationwide Population-Based Cohort Study.Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics
P2860
Q26825728-CA5CA9C9-A168-453E-A815-0F7AAB5774B0Q26849372-7EFF19F3-1099-4995-A8E2-38597469E21FQ26865575-38AECCFF-86D6-4033-A7B3-50F5D2409F2FQ28393758-C7CA7A0C-F2E4-486B-BE34-DD8F78934234Q30416509-78821927-87B0-4661-9CFE-15BA5FF8871AQ30422446-E82B8899-FDF4-4698-AFB3-6D148529991EQ30833442-5531BF12-01DA-405F-9D65-D8610411EEDDQ30974376-CDD0C1CB-25A9-4CD2-83B0-AD4700695727Q31113647-0DE8B082-1A5B-4D26-B509-E51F5333117FQ31133096-A776644D-9D0B-4A16-BE3F-9552E0BD6775Q33701953-EFB6F246-D14A-487E-886E-9B3B7C47C4FCQ33914708-DD79E48D-2C4A-4BA1-8B78-CA273306328BQ34001867-91BA6C29-E88E-4297-BC36-FCA7232C9D8DQ34001913-123AFF8E-0BD8-45A6-8F76-53C0B8950C5CQ34056132-35AF9367-D4D5-4989-8B70-6A24CB0867EAQ34099680-CAB4CD0D-A7C2-4B3E-AFB9-B0858DA08626Q34144164-F3CA35C3-CFAA-4A67-A2BE-4D42CAACF40CQ34157856-4C068DD6-B806-4AA0-83F9-705D79EABE37Q34254280-C04C7600-C6E0-446B-B2D7-94F9B883C5AFQ34463743-2CB79472-27B8-4CF4-9635-9EB63D6D5D1BQ34514319-F9A71E3F-C305-4B05-A04C-56C6B014A180Q34651525-EDC21BCB-0BA2-42DA-90A8-CCEC32CABEB6Q34778336-D970BCF6-1061-4E6C-AD8A-332F0649BB18Q35623434-9EB130DD-4393-45CF-B57A-897835354E1AQ35666013-CBEB2738-97AD-4030-9148-71EDE9564444Q35687073-F34023DF-73F2-43AB-989A-6E2634012213Q35725526-B80E142A-A30E-48DA-94AD-766E0093DBECQ35774970-CCBFF351-7AF4-4F40-B0CA-740B4F394C40Q35933863-E507E65A-18B8-4B77-A845-3FD97F8F6731Q36132510-91326626-4622-4E83-A4DC-F6BF1FA2ED17Q36320341-01AC021B-6B57-41D2-A375-89F8F00541C1Q36342944-408E74D2-31A0-4B33-BEB0-DF59AA3B44E8Q36363886-0CB8051B-3C95-4BF4-BB7A-8BF67A49192FQ36371615-66A84339-A080-4E2F-808D-57E1C9F8FF05Q36380007-9177F9F6-52ED-4435-85D7-1992C0011C27Q36447771-DDD12599-A2CC-4AA0-9712-A405A9195BDEQ36491998-39F33F0A-FB53-446F-A6C6-313EC8629BABQ36631292-8A551025-9BF0-41B6-82A5-7A74743DBAB7Q36700347-0A0F5D7B-9D55-4893-8F91-664C6EDD4D0FQ37056117-5100C344-2EAA-43F0-9C9B-3A75BAB0E8D1
P2860
Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Adjusting effect estimates for ...... propensity score calibration.
@ast
Adjusting effect estimates for ...... propensity score calibration.
@en
type
label
Adjusting effect estimates for ...... propensity score calibration.
@ast
Adjusting effect estimates for ...... propensity score calibration.
@en
prefLabel
Adjusting effect estimates for ...... propensity score calibration.
@ast
Adjusting effect estimates for ...... propensity score calibration.
@en
P2093
P2860
P356
P1476
Adjusting effect estimates for ...... propensity score calibration.
@en
P2093
Jerry Avorn
Robert J Glynn
Sebastian Schneeweiss
P2860
P304
P356
10.1093/AJE/KWI192
P407
P50
P577
2005-06-29T00:00:00Z